![]() Niclosamide-13C6 monohydrate structure
|
Common Name | Niclosamide-13C6 monohydrate | ||
---|---|---|---|---|
CAS Number | 1325559-12-3 | Molecular Weight | 351.09 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C713C6H10Cl2N2O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Niclosamide-13C6 monohydrateNiclosamide-13C6 (monohydrate) is the 13C labeled Niclosamide monohydrate[1]. Niclosamide (BAY2353) monohydrate is an orally active antihelminthic agent used in parasitic infection research[2]. Niclosamide monohydrate is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells[5]. Niclosamide monohydrate has biological activities against cancer, and inhibits DNA replication in Vero E6 cells[3][4][6]. |
Name | Niclosamide-13C6 monohydrate |
---|
Description | Niclosamide-13C6 (monohydrate) is the 13C labeled Niclosamide monohydrate[1]. Niclosamide (BAY2353) monohydrate is an orally active antihelminthic agent used in parasitic infection research[2]. Niclosamide monohydrate is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells[5]. Niclosamide monohydrate has biological activities against cancer, and inhibits DNA replication in Vero E6 cells[3][4][6]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
[3]. Wei Chen, et al. Niclosamide: Beyond an antihelminthic drug. Cell Signal. 2018 Jan41:89-96. |
Molecular Formula | C713C6H10Cl2N2O5 |
---|---|
Molecular Weight | 351.09 |